Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.


Journal

Genetic epidemiology
ISSN: 1098-2272
Titre abrégé: Genet Epidemiol
Pays: United States
ID NLM: 8411723

Informations de publication

Date de publication:
07 2020
Historique:
received: 11 10 2019
revised: 13 01 2020
accepted: 13 02 2020
pubmed: 3 3 2020
medline: 13 11 2020
entrez: 3 3 2020
Statut: ppublish

Résumé

Previous transcriptome-wide association studies (TWAS) have identified breast cancer risk genes by integrating data from expression quantitative loci and genome-wide association studies (GWAS), but analyses of breast cancer subtype-specific associations have been limited. In this study, we conducted a TWAS using gene expression data from GTEx and summary statistics from the hitherto largest GWAS meta-analysis conducted for breast cancer overall, and by estrogen receptor subtypes (ER+ and ER-). We further compared associations with ER+ and ER- subtypes, using a case-only TWAS approach. We also conducted multigene conditional analyses in regions with multiple TWAS associations. Two genes, STXBP4 and HIST2H2BA, were specifically associated with ER+ but not with ER- breast cancer. We further identified 30 TWAS-significant genes associated with overall breast cancer risk, including four that were not identified in previous studies. Conditional analyses identified single independent breast-cancer gene in three of six regions harboring multiple TWAS-significant genes. Our study provides new information on breast cancer genetics and biology, particularly about genomic differences between ER+ and ER- breast cancer.

Identifiants

pubmed: 32115800
doi: 10.1002/gepi.22288
pmc: PMC7987299
mid: NIHMS1658893
doi:

Substances chimiques

Estrogens 0
Receptors, Estrogen 0
STXBP4 protein, human 0
Vesicular Transport Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

442-468

Subventions

Organisme : NHLBI NIH HHS
ID : HHSN268201100004I
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA064277
Pays : United States
Organisme : NCI NIH HHS
ID : U19 CA148112
Pays : United States
Organisme : NCI NIH HHS
ID : N02CP11019
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA164917
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA199277
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA179715
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA128931
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100001I
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA156733
Pays : United States
Organisme : Cancer Research UK
ID : C1275/A19187
Pays : United Kingdom
Organisme : Intramural NIH HHS
ID : Z01 CP010119
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA164973
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA176785
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA089085
Pays : United States
Organisme : NCI NIH HHS
ID : RC4 CA153828
Pays : United States
Organisme : Cancer Research UK
ID : C570/A16491
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C1287/A10710
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : P50 CA125183
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA087969
Pays : United States
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : UM1 CA164920
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA097396
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA176726
Pays : United States
Organisme : Cancer Research UK
ID : C8221/A19170
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R37 CA070867
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA176726
Pays : United States
Organisme : Cancer Research UK
ID : C1275/C22524
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R01 CA092447
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 ES049030
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100046C
Pays : United States
Organisme : Cancer Research UK
ID : C1287/A16563
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R01 CA058860
Pays : United States
Organisme : Cancer Research UK
ID : C12292/A11174
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C490/A10124
Pays : United Kingdom
Organisme : CIHR
ID : CRN‐87521
Pays : Canada
Organisme : Medical Research Council
ID : MC_UU_12023/20
Pays : United Kingdom
Organisme : WHI NIH HHS
ID : HHSN268201100003C
Pays : United States
Organisme : Medical Research Council
ID : MR/N003284/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C5047/A10692
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : K07 CA092044
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000124
Pays : United States
Organisme : Cancer Research UK
ID : C490/A16561
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : P50 CA058223
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA100374
Pays : United States
Organisme : Medical Research Council
ID : 1000143
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C18281/A19169
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : U01 CA116167
Pays : United States
Organisme : Cancer Research UK
ID : C5047/A8384
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA128978
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA047147
Pays : United States
Organisme : NCI NIH HHS
ID : N02CP21003
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA051008
Pays : United States
Organisme : Medical Research Council
ID : G0401527
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R01 CA116167
Pays : United States
Organisme : NCI NIH HHS
ID : U19 CA148537
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW009112
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA148667
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA177150
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA116201
Pays : United States
Organisme : NIA NIH HHS
ID : HHSN271201100004C
Pays : United States
Organisme : Cancer Research UK
ID : C1275/A11699
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R01 CA063464
Pays : United States
Organisme : Department of Health
ID : PGFAR 0707‐10031
Pays : United Kingdom
Organisme : CIHR
ID : GPH‐129344
Pays : Canada
Organisme : NIGMS NIH HHS
ID : P20 GM130423
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA186107
Pays : United States
Organisme : Medical Research Council
ID : MR/M012190/1
Pays : United Kingdom
Organisme : WHI NIH HHS
ID : HHSN268201100002C
Pays : United States
Organisme : Cancer Research UK
ID : C5047/A15007
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000143
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : N02CP65504
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA063464
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA077398
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA054281
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA132839
Pays : United States
Organisme : Cancer Research UK
ID : C8620/A8372/A15106
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : P30 CA068485
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA058860
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA ES102245
Pays : United States
Organisme : NHGRI NIH HHS
ID : R01 HG009120
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA098758
Pays : United States
Organisme : NCI NIH HHS
ID : N01 CN025403
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 ES044005
Pays : United States
Organisme : NCI NIH HHS
ID : U19 CA148065
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA069664
Pays : United States
Organisme : Department of Health
ID : IS‐BRC‐1215‐20007
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C1275/A15956
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : HHSN268201100003I
Pays : United States
Organisme : Medical Research Council
ID : G0500300
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : HHSN268201100002I
Pays : United States
Organisme : Cancer Research UK
ID : C1281/A12014
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH101244
Pays : United States
Organisme : NCI NIH HHS
ID : R03 CA224196
Pays : United States
Organisme : Medical Research Council
ID : MC_PC_14105
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C8197/A16565
Pays : United Kingdom
Organisme : Intramural NIH HHS
ID : Z01 ES049033
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA192393
Pays : United States
Organisme : Cancer Research UK
ID : C1287/A10118
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R37 CA054281
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA120120
Pays : United States
Organisme : WHI NIH HHS
ID : HHSN268201100001C
Pays : United States
Organisme : NCI NIH HHS
ID : K24 CA169004
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA164973
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA140286
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA047305
Pays : United States
Organisme : WHI NIH HHS
ID : HHSN268201100004C
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA182910
Pays : United States
Organisme : Cancer Research UK
ID : 10119
Pays : United Kingdom

Informations de copyright

© 2020 The Authors. Genetic Epidemiology published by Wiley Periodicals, Inc.

Références

Nat Genet. 2013 Apr;45(4):392-8, 398e1-2
pubmed: 23535733
J Natl Cancer Inst. 2015 Apr 08;107(5):
pubmed: 25855707
Eur J Hum Genet. 2009 Jul;17(7):855-6
pubmed: 19092772
Cell. 2013 Nov 7;155(4):934-47
pubmed: 24119843
Am J Hum Genet. 2011 Jan 7;88(1):76-82
pubmed: 21167468
Cancer Res. 2010 Dec 1;70(23):9742-54
pubmed: 21118973
Nat Genet. 2015 Sep;47(9):1091-8
pubmed: 26258848
Science. 2015 May 8;348(6235):648-60
pubmed: 25954001
Genet Epidemiol. 2005 Jul;29(1):1-11
pubmed: 15880399
Nat Genet. 2019 Apr;51(4):675-682
pubmed: 30926970
Nat Genet. 2016 Mar;48(3):245-52
pubmed: 26854917
Nat Genet. 2006 Nov;38(11):1239-41
pubmed: 17033622
Nat Genet. 2017 Dec;49(12):1767-1778
pubmed: 29058716
Nat Genet. 2016 Oct;48(10):1279-83
pubmed: 27548312
Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):126-135
pubmed: 27697780
Genet Epidemiol. 2012 Apr;36(3):274-91
pubmed: 22714938
Mol Oncol. 2010 Jun;4(3):174-91
pubmed: 20542480
Nat Genet. 2014 Aug;46(8):886-90
pubmed: 25038754
Nat Genet. 2018 Jul;50(7):968-978
pubmed: 29915430
PLoS Genet. 2017 Sep 28;13(9):e1006727
pubmed: 28957356
Bioinformatics. 2014 Oct 15;30(20):2906-14
pubmed: 24990607
Nat Genet. 2016 Apr;48(4):374-86
pubmed: 26928228
Nat Genet. 2015 Apr;47(4):373-80
pubmed: 25751625
PLoS Comput Biol. 2008 Mar 21;4(3):e1000032
pubmed: 18369425
PLoS Med. 2010 May 25;7(5):e1000279
pubmed: 20520800
Sci Rep. 2016 Sep 07;6:32512
pubmed: 27600471
PLoS Genet. 2009 Jun;5(6):e1000529
pubmed: 19543373
Breast Cancer Res Treat. 2013 Jul;140(2):427-34
pubmed: 23893088
Am J Hum Genet. 2017 Mar 2;100(3):473-487
pubmed: 28238358
Nat Genet. 2007 Mar;39(3):352-8
pubmed: 17293864
Hum Mol Genet. 2015 Jan 1;24(1):285-98
pubmed: 25168388
Nature. 2007 Jun 28;447(7148):1087-93
pubmed: 17529967
Nat Commun. 2019 Apr 15;10(1):1741
pubmed: 30988301
Nat Genet. 2019 Apr;51(4):592-599
pubmed: 30926968
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Genet Epidemiol. 2018 Jul;42(5):418-433
pubmed: 29808603
Oncogene. 2014 May 15;33(20):2610-9
pubmed: 23792445
Breast Cancer Res Treat. 2010 Jan;119(1):201-11
pubmed: 19360465
Hered Cancer Clin Pract. 2013 Sep 11;11(1):12
pubmed: 24025454
Bioinformatics. 2010 Sep 1;26(17):2190-1
pubmed: 20616382
Nature. 2017 Nov 2;551(7678):92-94
pubmed: 29059683
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Natl Cancer Inst. 2011 Feb 2;103(3):250-63
pubmed: 21191117
Nat Genet. 2010 Jul;42(7):565-9
pubmed: 20562875
Nat Methods. 2011 Dec 04;9(2):179-81
pubmed: 22138821
PLoS Genet. 2010 Apr 01;6(4):e1000888
pubmed: 20369019
J Clin Oncol. 2008 Sep 10;26(26):4282-8
pubmed: 18779615
Breast. 2013 Aug;22 Suppl 2:S48-9
pubmed: 24074792
PLoS Genet. 2017 Mar 31;13(3):e1006690
pubmed: 28362817
Nat Genet. 2010 Jun;42(6):504-7
pubmed: 20453838

Auteurs

Helian Feng (H)

Program in Genetic Epidemiology and Statistical Genetics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.

Alexander Gusev (A)

Dana-Farber Cancer Institute, Boston, Massachusetts.

Bogdan Pasaniuc (B)

UCLA Path & Lab Med, Los Angeles, California.

Lang Wu (L)

Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii.

Jirong Long (J)

Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.

Zomoroda Abu-Full (Z)

Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.

Kristiina Aittomäki (K)

Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Irene L Andrulis (IL)

Fred A, Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Hoda Anton-Culver (H)

Department of Epidemiology, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, California.

Antonis C Antoniou (AC)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Adalgeir Arason (A)

Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland.
BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Volker Arndt (V)

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Kristan J Aronson (KJ)

Department of Public Health Sciences, and Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.

Banu K Arun (BK)

Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.

Ella Asseryanis (E)

Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

Paul L Auer (PL)

Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin.

Jacopo Azzollini (J)

Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Judith Balmaña (J)

High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.

Rosa B Barkardottir (RB)

Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland.
BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Daniel R Barnes (DR)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Daniel Barrowdale (D)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Matthias W Beckmann (MW)

Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.

Sabine Behrens (S)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Javier Benitez (J)

Centro de Investigaci-n en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.

Marina Bermisheva (M)

Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.

Katarzyna Białkowska (K)

Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.

Ana Blanco (A)

Centro de Investigaci-n en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
Fundaci-n Pœblica Galega Medicina Xen-mica, Santiago De Compostela, Spain.
Instituto de Investigacion Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.

Carl Blomqvist (C)

Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Department of Oncology, University Hospital, Karolinska Institute, Stockholm, Sweden.

Bram Boeckx (B)

VIB Center for Cancer Biology, VIB, Leuven, Belgium.
Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium.

Natalia V Bogdanova (NV)

Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
NN Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.

Stig E Bojesen (SE)

Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Manjeet K Bolla (MK)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Bernardo Bonanni (B)

Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Ake Borg (A)

Department of Oncology, Lund University and Skåne University Hospital, Lund, Sweden.

Hiltrud Brauch (H)

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
iFIT-Cluster of Excellence, University of Tuebingen, Tuebingen, Germany.
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.

Hermann Brenner (H)

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.

Ignacio Briceno (I)

Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia.
Medical Faculty, Universidad de La Sabana, Bogota, Colombia.

Annegien Broeks (A)

Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Thomas Brüning (T)

Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany.

Barbara Burwinkel (B)

Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, University of Heidelberg, Heidelberg, Germany.

Qiuyin Cai (Q)

Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.

Trinidad Caldés (T)

Medical Oncology Department, Hospital Cl'nico San Carlos, Instituto de Investigaci-n Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Maria A Caligo (MA)

Section of Molecular Genetics, Dept, of Laboratory Medicine, University Hospital of Pisa, Pisa, Italy.

Ian Campbell (I)

Research Department, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.

Sander Canisius (S)

Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Division of Molecular Carcinogenesis, The Netherlands Cancer Institute-Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.

Daniele Campa (D)

Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Brian D Carter (BD)

Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, Georgia.

Jonathan Carter (J)

Department of Gynaecological Oncology, Chris OÕBrien Lifehouse and The University of Sydney, Camperdown, New South Wales, Australia.

Jose E Castelao (JE)

Oncology and Genetics Unit, Instituto de Investigacion Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain.

Jenny Chang-Claude (J)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Stephen J Chanock (SJ)

Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Hans Christiansen (H)

Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.

Wendy K Chung (WK)

Departments of Pediatrics and Medicine, Columbia University, New York, New York.

Kathleen B M Claes (KBM)

Centre for Medical Genetics, Ghent University, Gent, Belgium.

Christine L Clarke (CL)

Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
Department of Tumour Biology, INSERM U830, Paris, France.
Institut Curie, Paris, France.
Mines ParisTech, Fontainebleau, France.
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Center for Hereditary Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Fergus J Couch (FJ)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.

Angela Cox (A)

Department of Oncology and Metabolism, Sheffield Institute for Nucleic Acids (SInFoNiA), University of Sheffield, Sheffield, UK.

Simon S Cross (SS)

Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK.

Cezary Cybulski (C)

Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.

Kamila Czene (K)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Mary B Daly (MB)

Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Miguel de la Hoya (M)

Medical Oncology Department, Hospital Cl'nico San Carlos, Instituto de Investigaci-n Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Kim De Leeneer (K)

Centre for Medical Genetics, Ghent University, Gent, Belgium.

Joe Dennis (J)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Peter Devilee (P)

Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Orland Diez (O)

Hereditary Cancer Genetics Group, Area of Clinical and Molecular Genetics, Vall dHebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Barcelona, Spain.
Clinical and Molecular Genetics Area, University Hospital Vall dHebron, Barcelona, Spain.

Susan M Domchek (SM)

Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Thilo Dörk (T)

Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.

Isabel Dos-Santos-Silva (I)

Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Alison M Dunning (AM)

Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.

Miriam Dwek (M)

Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK.

Diana M Eccles (DM)

Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK.

Bent Ejlertsen (B)

Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Carolina Ellberg (C)

Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.

Christoph Engel (C)

Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
LIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.

Mikael Eriksson (M)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Peter A Fasching (PA)

Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, California.

Olivia Fletcher (O)

The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.

Henrik Flyger (H)

Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.

Florentia Fostira (F)

Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritosဩ, Athens, Greece.

Eitan Friedman (E)

The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.

Lin Fritschi (L)

School of Public Health, Curtin University, Perth, Western Australia, Australia.

Debra Frost (D)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Marike Gabrielson (M)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Patricia A Ganz (PA)

Schools of Medicine and Public Health, Division of Cancer Prevention & Control Research, Jonsson Comprehensive Cancer Centre, UCLA, Los Angeles, California.

Susan M Gapstur (SM)

Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, Georgia.

Judy Garber (J)

Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts.

Montserrat García-Closas (M)

Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.

José A García-Sáenz (JA)

Medical Oncology Department, Hospital Cl'nico San Carlos, Instituto de Investigaci-n Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Mia M Gaudet (MM)

Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, Georgia.

Graham G Giles (GG)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Gord Glendon (G)

Fred A, Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.

Andrew K Godwin (AK)

Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, Kanas.

Mark S Goldberg (MS)

Department of Medicine, McGill University, Montreal, Quebec, Canada.
Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada.

David E Goldgar (DE)

Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah.

Anna González-Neira (A)

Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.

Mark H Greene (MH)

Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.

Jacek Gronwald (J)

Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.

Pascal Guénel (P)

Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France.

Christopher A Haiman (CA)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.

Per Hall (P)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Department of Oncology, Sšdersjukhuset, Stockholm, Sweden.

Ute Hamann (U)

Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Christopher Hake (C)

City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California.

Wei He (W)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Jane Heyworth (J)

School of Population and Global Health, The University of Western Australia, Perth, Western Australia, Australia.

Frans B L Hogervorst (FBL)

Family Cancer Clinic, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Antoinette Hollestelle (A)

Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Maartje J Hooning (MJ)

Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Robert N Hoover (RN)

Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

John L Hopper (JL)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.

Guanmengqian Huang (G)

Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Peter J Hulick (PJ)

Center for Medical Genetics, NorthShore University HealthSystem, Evanston, Illinois.
The University of Chicago Pritzker School of Medicine, Chicago, Illinois.

Keith Humphreys (K)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Evgeny N Imyanitov (EN)

NN Petrov Institute of Oncology, St. Petersburg, Russia.
Australian Breast Cancer Tissue Bank, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Coordinating Center, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.
Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.

Claudine Isaacs (C)

Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.

Milena Jakimovska (M)

Research Centre for Genetic Engineering and Biotechnology 'Georgi D, Efremov', Macedonian Academy of Sciences and Arts, Skopje Republic of North Macedonia, North Macedonia.

Anna Jakubowska (A)

Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland.

Paul James (P)

Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.

Ramunas Janavicius (R)

State Research Institute Innovative Medicine Center, Vilnius, Lithuania.

Rachel C Jankowitz (RC)

Department of Medicine, Division of Hematology/Oncology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

Esther M John (EM)

Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.

Nichola Johnson (N)

The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.

Vijai Joseph (V)

Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York.

Audrey Jung (A)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Beth Y Karlan (BY)

David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California, Los Angeles, California.

Elza Khusnutdinova (E)

Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.
Department of Genetics and Fundamental Medicine, Bashkir State Medical University, Ufa, Russia.

Johanna I Kiiski (JI)

Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Irene Konstantopoulou (I)

Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritosဩ, Athens, Greece.

Vessela N Kristensen (VN)

Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Yael Laitman (Y)

The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel.

Diether Lambrechts (D)

VIB Center for Cancer Biology, VIB, Leuven, Belgium.
Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium.

Conxi Lazaro (C)

Molecular Diagnostic Unit, Hereditary Cancer Program, ICO-IDIBELL (Bellvitge Biomedical Research Institute, Catalan Institute of Oncology), CIBERONC, Barcelona, Spain.

Dominique Leroux (D)

Departement de Ge netique, CHU de Grenoble, Grenoble, France.

Goska Leslie (G)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Jenny Lester (J)

David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California, Los Angeles, California.

Fabienne Lesueur (F)

Institut Curie, Paris, France.
Mines ParisTech, Fontainebleau, France.
Genetic Epidemiology of Cancer Team, Inserm U900, Paris, France.

Noralane Lindor (N)

Department of Health Sciences Research, Mayo Clinic, Scottsdale, Arizona.

Sara Lindström (S)

Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington.
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

Wing-Yee Lo (WY)

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
iFIT-Cluster of Excellence, University of Tuebingen, Tuebingen, Germany.

Jennifer T Loud (JT)

Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.

Jan Lubiński (J)

Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.

Enes Makalic (E)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.

Arto Mannermaa (A)

Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.
Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.
Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.

Mehdi Manoochehri (M)

Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Siranoush Manoukian (S)

Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Sara Margolin (S)

Department of Oncology, Sšdersjukhuset, Stockholm, Sweden.
Department of Clinical Science and Education, Sšdersjukhuset, Karolinska Institutet, Stockholm, Sweden.

John W M Martens (JWM)

Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Maria E Martinez (ME)

Moores Cancer Center, University of California San Diego, La Jolla, California.
Department of Family Medicine and Public Health, University of California San Diego, La Jolla, California.

Laura Matricardi (L)

Immunology and Molecular Oncology Unit, Veneto Institute of Oncology ÊIOV-IRCCS, Padua, Italy.

Tabea Maurer (T)

Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Dimitrios Mavroudis (D)

Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece.

Lesley McGuffog (L)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Alfons Meindl (A)

Department of Gynecology and Obstetrics, Ludwig Maximilian University of Munich, Munich, Germany.

Usha Menon (U)

MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London, UK.

Kyriaki Michailidou (K)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Department of Electron Microscopy/Molecular Pathology and The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.

Pooja M Kapoor (PM)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Faculty of Medicine, University of Heidelberg, Heidelberg, Germany.

Austin Miller (A)

NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, New York.

Marco Montagna (M)

Immunology and Molecular Oncology Unit, Veneto Institute of Oncology ÊIOV-IRCCS, Padua, Italy.

Fernando Moreno (F)

Medical Oncology Department, Hospital Cl'nico San Carlos, Instituto de Investigaci-n Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Lidia Moserle (L)

Immunology and Molecular Oncology Unit, Veneto Institute of Oncology ÊIOV-IRCCS, Padua, Italy.

Anna M Mulligan (AM)

Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.

Taru A Muranen (TA)

Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Katherine L Nathanson (KL)

Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Susan L Neuhausen (SL)

Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California.

Heli Nevanlinna (H)

Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Ines Nevelsteen (I)

Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.

Finn C Nielsen (FC)

Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Liene Nikitina-Zake (L)

Latvian Biomedical Research and Study Centre, Riga, Latvia.

Kenneth Offit (K)

Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York.
Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.

Edith Olah (E)

Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.

Olufunmilayo I Olopade (OI)

Center for Clinical Cancer Genetics, The University of Chicago, Chicago, Illinois.

Håkan Olsson (H)

Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.

Ana Osorio (A)

Centro de Investigaci-n en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.

Janos Papp (J)

Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.

Tjoung-Won Park-Simon (TW)

Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.

Michael T Parsons (MT)

Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Inge S Pedersen (IS)

Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.

Ana Peixoto (A)

Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.

Paolo Peterlongo (P)

Genome Diagnostics Program, IFOM-The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy.

Julian Peto (J)

Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Paul D P Pharoah (PDP)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.

Kelly-Anne Phillips (KA)

Research Department, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Department of Medicine Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Dijana Plaseska-Karanfilska (D)

Research Centre for Genetic Engineering and Biotechnology 'Georgi D, Efremov', Macedonian Academy of Sciences and Arts, Skopje Republic of North Macedonia, North Macedonia.

Bruce Poppe (B)

Centre for Medical Genetics, Ghent University, Gent, Belgium.

Nisha Pradhan (N)

Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York.

Karolina Prajzendanc (K)

Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.

Nadege Presneau (N)

Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK.

Kevin Punie (K)

Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.

Katri Pylkäs (K)

Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland.
Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland.

Paolo Radice (P)

Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.

Johanna Rantala (J)

Clinical Genetics, Karolinska Institutet, Stockholm, Sweden.

Muhammad Usman Rashid (MU)

Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan.

Gad Rennert (G)

Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.

Harvey A Risch (HA)

Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut.

Mark Robson (M)

Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.

Atocha Romero (A)

Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.

Emmanouil Saloustros (E)

Department of Oncology, University Hospital of Larissa, Larissa, Greece.

Dale P Sandler (DP)

Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina.

Catarina Santos (C)

Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.

Elinor J Sawyer (EJ)

Research Oncology, GuyÕs Hospital, King's College London, London, UK.

Marjanka K Schmidt (MK)

Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Daniel F Schmidt (DF)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Faculty of Information Technology, Monash University, Melbourne, Victoria, Australia.

Rita K Schmutzler (RK)

Center for Hereditary Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Minouk J Schoemaker (MJ)

Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.

Rodney J Scott (RJ)

Division of Molecular Medicine, Pathology North, John Hunter Hospital, Newcastle, New South Wales, Australia.
Discipline of Medical Genetics, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, New South Wales, Australia.
Hunter Medical Research Institute, John Hunter Hospital, Newcastle, New South Wales, Australia.

Priyanka Sharma (P)

Department of Internal Medicine, Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kanas.

Xiao-Ou Shu (XO)

Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.

Jacques Simard (J)

Genomics Center, Centre Hospitalier Universitaire de Quebec-Universite Laval, Research Center, Quebec City, Qubec, Canada.

Christian F Singer (CF)

Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

Anne-Bine Skytte (AB)

Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark.

Penny Soucy (P)

Genomics Center, Centre Hospitalier Universitaire de Quebec-Universite Laval, Research Center, Quebec City, Qubec, Canada.

Melissa C Southey (MC)

Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia.

John J Spinelli (JJ)

Population Oncology, BC Cancer, Vancouver, British of Columbia, Canada.
School of Population and Public Health, University of British Columbia, Vancouver, British of Columbia, Canada.

Amanda B Spurdle (AB)

Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Jennifer Stone (J)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
The Curtin UWA Centre for Genetic Origins of Health and Disease, Curtin University and University of Western Australia, Perth, Western Australia, Australia.

Anthony J Swerdlow (AJ)

Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.

William J Tapper (WJ)

Faculty of Medicine, University of Southampton, Southampton, UK.

Jack A Taylor (JA)

Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina.
Epigenetic and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina.

Manuel R Teixeira (MR)

Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal.

Mary Beth Terry (MB)

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.

Alex Teulé (A)

Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.

Mads Thomassen (M)

Department of Clinical Genetics, Odense University Hospital, Odence C, Denmark.

Kathrin Thöne (K)

Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Darcy L Thull (DL)

Department of Medicine, Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

Marc Tischkowitz (M)

Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada.
Department of Medical Genetics, University of Cambridge, Cambridge, UK.

Amanda E Toland (AE)

Department of Cancer Biology and Genetics, The Ohio State University, Columbus, Ohio.

Rob A E M Tollenaar (RAEM)

Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.

Diana Torres (D)

Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia.
Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Thérèse Truong (T)

Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France.

Nadine Tung (N)

Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Celine M Vachon (CM)

Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota.

Christi J van Asperen (CJ)

Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Ans M W van den Ouweland (AMW)

Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.

Elizabeth J van Rensburg (EJ)

Department of Genetics, University of Pretoria, Arcadia, South Africa.

Ana Vega (A)

Centro de Investigaci-n en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
Fundaci-n Pœblica Galega Medicina Xen-mica, Santiago De Compostela, Spain.
Instituto de Investigacion Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.

Alessandra Viel (A)

Division of Functional Onco-genomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.

Paula Vieiro-Balo (P)

Hospital Clínico Universitario (SERGAS), Universidad de Santiago de Compostela, CIMUS, Santiago de Compostela, España.

Qin Wang (Q)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Barbara Wappenschmidt (B)

Center for Hereditary Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Clarice R Weinberg (CR)

Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina.

Jeffrey N Weitzel (JN)

Clinical Cancer Genomics, City of Hope, Duarte, California.

Camilla Wendt (C)

Department of Clinical Science and Education, Sšdersjukhuset, Karolinska Institutet, Stockholm, Sweden.

Robert Winqvist (R)

Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland.
Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland.

Xiaohong R Yang (XR)

Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Drakoulis Yannoukakos (D)

Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritosဩ, Athens, Greece.

Argyrios Ziogas (A)

Department of Epidemiology, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, California.

Roger L Milne (RL)

Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.

Douglas F Easton (DF)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.

Georgia Chenevix-Trench (G)

Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Wei Zheng (W)

Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.

Peter Kraft (P)

Program in Genetic Epidemiology and Statistical Genetics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.

Xia Jiang (X)

Program in Genetic Epidemiology and Statistical Genetics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH